Free Trial

Acumen Pharmaceuticals (ABOS) SEC Filings & 10K Form

$2.87
-0.06 (-2.05%)
(As of 04:15 PM ET)

Recent Acumen Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/10/2024
4:26 PM
Acumen Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:40 PM
Acumen Pharmaceuticals (Issuer)
Drapkin Kimberlee C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:41 PM
Acumen Pharmaceuticals (Issuer)
Fountain Nathan B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:46 PM
Acumen Pharmaceuticals (Issuer)
Porter Derrell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:49 PM
Acumen Pharmaceuticals (Issuer)
Stalfort John A III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:51 PM
Acumen Pharmaceuticals (Issuer)
Stoppel Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:36 PM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:47 PM
Acumen Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
6:35 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
11:15 PM
Acumen Pharmaceuticals (Filer)
Form EFFECT
04/22/2024
3:33 PM
Acumen Pharmaceuticals (Filer)
Form ARS
04/22/2024
3:30 PM
Acumen Pharmaceuticals (Filer)
Form DEF 14A
04/22/2024
3:31 PM
Acumen Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
3:34 PM
Acumen Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2024
3:34 PM
Acumen Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/26/2024
8:16 AM
Acumen Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:42 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:05 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:32 AM
Acumen Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
02/06/2024
8:02 AM
Acumen Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G
02/01/2024
4:01 PM
Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
4:02 PM
Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
6:16 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
3:22 PM
Acumen Pharmaceuticals (Subject)
MURRAY JAMES B JR (Filed by)
Form SC 13G/A
01/19/2024
6:04 PM
Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:05 PM
Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:05 PM
Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:06 PM
Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
6:07 PM
Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:35 PM
Acumen Pharmaceuticals (Subject)
OConnell Daniel Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/19/2024
3:36 PM
Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
3:27 PM
Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
3:28 PM
Acumen Pharmaceuticals (Subject)
Barton Russell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
3:29 PM
Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
7:42 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:33 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:20 PM
Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:21 PM
Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:22 PM
Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:23 PM
Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:18 PM
Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Top Stock Unveiled! (Ad)

Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

Get Your Free Report
12/04/2023
6:45 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
6:20 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2023
5:31 PM
Acumen Pharmaceuticals (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
10:46 AM
Acumen Pharmaceuticals (Subject)
Ives Jeffrey L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
6:33 AM
Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ABOS) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners